SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Social media platforms are seeing a surge in speculative chatter as investors debate the legitimacy of tokenized pre-IPO assets, with many users warning of potential scams while others track news regarding a long-rumored SpaceX public offering. Community members are actively analyzing the aerospace sector, focusing on the potential impact of a high-profile IPO and debating whether current market excitement reflects genuine valuation or a bubble driven by retail FOMO.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is attracting significant attention as investors speculate on its role in the AI-agent infrastructure space, with the community actively discussing potential institutional interest and long-term utility. Despite recent price volatility, supporters are highlighting bullish ecosystem developments and active development as reasons to maintain a long-term position.

Swell

The community is actively debating the potential of Swell, with supporters highlighting its liquid staking utility, institutional backing, and low market cap as key drivers for long-term growth. Conversely, critics frequently dismiss the asset as a speculative project, pointing to recurring price volatility and concerns over supply issuance as reasons for caution.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp. (EMAT) is gaining momentum as investors weigh its potential as a vertically integrated domestic rare earth magnet manufacturer against concerns regarding its micro-float and high insider ownership. Community discussion is split between excitement over the stock's positioning as a strategic alternative to foreign supply chains and caution regarding its characteristic high volatility and potential for sharp price swings.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

League of Degens 

The community is actively discussing $DEGEN, pointing to a mix of optimism surrounding potential exchange listings and a new beta app while others express frustration over token performance. Investors remain hyper-focused on upcoming project catalysts and social media branding as they debate whether the token is currently at a critical accumulation phase.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following an exclusive U.S. supply agreement for the Tokyo strain of BCG to address the ongoing domestic shortage, a move the community views as a strategic breakthrough that strengthens the company's competitive position against major pharmaceutical players. Investors are actively discussing the potential for accelerated regulatory pathways, the synergy between this supply and Anktiva, and the anticipation of further catalysts being revealed at the upcoming American Urological Association conference.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors monitor Q4 earnings results and weigh the ongoing growth of immunology blockbusters Skyrizi and Rinvoq against the managed decline of Humira revenues. Meanwhile, community discussions are heavily focused on the company's potential M&A appetite in the obesity and oncology sectors, with retail sentiment remaining vigilant regarding potential competitive threats and pipeline expansion strategies.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: United States, Germany, and Other. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

WW International Inc - Ordinary Shares - New

WW International, Inc. Common Stock

WW International is gaining traction as investors speculate on a turnaround driven by strategic partnerships with GLP-1 medication providers and debt-reduction efforts. The community remains divided, with some betting on a successful pivot toward clinical weight-loss solutions while others remain skeptical due to the company's historical financial struggles and competitive pressure.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is experiencing a surge in investor interest driven by strong prescription growth, successful patent protection, and a clear path toward operating profitability in the coming quarters. The community is actively discussing the stock's potential for acquisition by larger pharmaceutical firms, while closely monitoring the ongoing battle against high short interest and institutional accumulation patterns.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render Token is currently capturing significant attention as investors double down on decentralized AI infrastructure and GPU-based compute plays. The community is heavily focused on the protocol's utility in the expanding AI landscape, with many traders actively accumulating positions while discussing its long-term potential compared to other artificial intelligence and DePIN projects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NEW YORK, March 20, 2026 /PRNewswire/ -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4646130-1&amp;h=3378504652&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>, a provider of ETFs designed for sophisticated investors and professional traders, announced that it has surpassed $3 billion in assets under management (AUM) in under two years since its launch. Tradr attributes this success to its formula – identifying unmet market demand from traders and active investors, and then working to satisfy that demand with timely, precision trading products.Since its launch in May 2024, Tradr now has 8 ETFs with more than $100m in AUM, including:<ul><li>Tradr 2X Long SNDX Daily ETF (SNXX) - $786m &nbsp;</li><li>Tradr 2X Long LITE Daily ETF (LITX) - $417m &nbsp;</li><li>Tradr 2X Long ASTS Daily ETF (ASTX) - $282m &nbsp;</li><li>Tradr 2X Short TSLA Daily ETF (TSLQ) - $182m &nbsp;</li><li>Tradr 2X Long NBIS Daily ETF (NEBX) - $143m &nbsp;</li><li>Tradr 2X Long APP Daily ETF (APPX) - $136m &nbsp;</li><li>Tradr 2X Long CRWV Daily ETF (CWVX) - $111m &nbsp;</li><li>Tradr 2X Long Innovation 100 Monthly ETF (MQQQ) - $109m</li></ul>"Crossing $3 billion in AUM marks another significant step in Tradr's growth trajectory," said Russell Tencer, President of Tradr ETFs. "Investors are increasingly turning to our precision-built leveraged ETFs, and we believe this momentum positions us as a clear leader in the next phase of the category's evolution."Tradr now offers 67 ETFs and, as a pioneer of leveraged ETFs, has rapidly gained traction with active traders, institutions and retail investors alike. It continues to expand its product line by targeting stocks that traders follow, including high-volume names with elevated volatility, recent IPOs, and companies in innovative sectors such as AI storage and infrastructure, high-bandwidth memory, optical networking, satellite constellations and broadband, and autonomous transportation.For detailed information on Tradr ETFs and the significant risks involved with inverse and leveraged ETFs, please visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4646130-1&amp;h=2073319261&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4646130-1&amp;h=3378504652&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a> are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4646130-1&amp;h=2073319261&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000875SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Tradr ETFs Reaches $3 Billion AUM Milestone in Under Two Years

Reflects strong enthusiasm for the Tradr family of single-stock and calendar reset leveraged ETFs

Others

NEW YORK, Dec. 1, 2025 /PRNewswire/ -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4568940-1&amp;h=2903607757&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>,&nbsp;a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4568940-1&amp;h=2907657594&amp;u=https%3A%2F%2Fwww.tradretfs.com%2Fsmq&amp;a=Tradr+1X+Short+Innovation+100+Monthly+ETF+(Cboe%3A+SMQ)">Tradr 1X Short Innovation 100 Monthly ETF (Cboe: SMQ)</a>. The fund seeks investment results that correspond to the inverse (–100%) of the calendar month performance of the Invesco QQQ® (the "Innovation 100"). SMQ is the first ever ETF to offer inverse monthly-reset exposure tied to the Invesco QQQ®, giving traders a new tool to express bearish views with a longer perspective than traditional daily-reset leveraged ETFs.SMQ complements Tradr's existing long product, the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4568940-1&amp;h=3486560007&amp;u=https%3A%2F%2Fwww.tradretfs.com%2FMQQQ-2X-Long-Triple-Q-Monthly-ETF&amp;a=Tradr+2X+Long+Innovation+100+Monthly+ETF+(Nasdaq%3A+MQQQ)">Tradr 2X Long Innovation 100 Monthly ETF (Nasdaq: </a><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-smq-the-first-monthly-reset-inverse-etf-tracking-invesco-qqq-302629225.html#financial-modal">MQQQ</a>). Together, MQQQ and SMQ form the only pair of leveraged ETFs offering a calendar month performance reset, supporting both bullish and bearish views on one of the most liquid and widely watched ETFs in the world."In trading, oftentimes you have the direction of the trade correct, but the timing may go against you, especially when holding a daily reset leveraged strategy over the course of several weeks. Our goal was to create a directional or hedging tool that could better reflect a trader's medium-term bearish view," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "With SMQ, we are extending the monthly-reset category that we pioneered with MQQQ to give investors a new tool that could be more consistent with their return expectations."The launch of SMQ reflects Tradr's ongoing commitment to innovation in leveraged ETFs. While most leveraged and inverse ETFs reset their performance daily — potentially creating significant path dependency and compounding issues — Tradr's monthly-reset design seeks to reduce those impacts for traders focused on multi-week themes, charts, macro catalysts, or full-month positioning.In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia. With today's listing, Tradr's lineup has grown to 54 leveraged ETFs representing nearly $2 billion in assets under management. Tradr's strategies can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4568940-1&amp;h=534396252&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4568940-1&amp;h=2903607757&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>&nbsp;are designed for sophisticated investors and professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4568940-1&amp;h=534396252&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000805SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Tradr Launches SMQ, the First Monthly Reset Inverse ETF Tracking Invesco QQQ®

SMQ seeks -100% of the calendar month performance of Invesco QQQ®, complementing Tradr's 2X long monthly reset ETF, MQQQ

Tradr Launches SMQ, the First Monthly Reset Inverse ETF Tracking Invesco QQQ

Tradr Launches SMQ, the First Monthly Reset Inverse ETF Tracking Invesco QQQ Tradr Launches SMQ, the First Monthly Reset Inverse ETF Tracking Invesco QQQ PR Newswire NEW YORK, Dec. 1, 2025 SMQ seeks...

MQQQ
Tradr 2X Long Innovation 100 Monthly ETF

Feed

News

Sentiment

Fundamentals

Info

Latest MQQQ News

MQQQTradr 2X Long Innovation 100 Monthly ETF